Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Roche Holding AG Basel American Depositary Shares (OP: RHHBY )

41.88 +0.77 (+1.87%)
Streaming Delayed Price Updated: 2:21 PM EDT, May 23, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 8,457,012
Open 41.56
Bid (Size) N/A (0)
Ask (Size) N/A (0)
Prev. Close 41.11
Today's Range 41.56 - 42.10
52wk Range 39.32 - 53.86
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Seagen Posts Encouraging Data From Tucatinib Combo Trial In Colorectal Cancer
 
Via Benzinga
Teva Pharmaceutical Shares Real-World Data Of ProAir Digihaler In Asthma Patients
 
Via Benzinga

Performance

YTD
-18.93%
-18.93%
1 Month
-12.53%
-12.53%
3 Month
-10.26%
-10.26%
6 Month
-14.43%
-14.43%
1 Year
-2.97%
-2.97%

More News

Read More
Current Report: Roche Holding
Via Talk Markets
The OTC Markets' Most Active Securities Welcomes New Names And Experiences A Reshuffle In April
Via Benzinga
Why Roche's Flop In Lung Cancer Hammered Arcus, Iteos And Others
Via Investor's Business Daily
The Daily Biotech Pulse: Veru Shares Up On COVID Candidate Update, FDA Approves Lilly's COVID Treatment, Latest On Sanofi-AstraZeneca RSV Vaccine
Via Benzinga
Genentech's Tiragolumab/Tecentriq Fails On Progression Free Survival In PD-L1-High Metastatic Lung Cancer
Via Benzinga
Genentech Reports Interim Results for Phase III SKYSCRAPER-01 Study in PD-L1-High Metastatic Non-Small Cell Lung Cancer
From Genentech
Via Business Wire
Market Selloff
Via Talk Markets
Roche Releases More Evrysdi Data For Very Young Infants With SMA
Via Benzinga
New Three-Year Data for Genentech’s Evrysdi (risdiplam) Show Long-Term Improvements in Survival and Motor Milestones in Babies With Type 1 Spinal Muscular Atrophy (SMA)
From Genentech
Via Business Wire
Novartis Posts Higher Q1 Earnings, Sales On Strong Sandoz, Entresto; Backs 2022 Outlook
Via Benzinga
Roche's CEO Warns Russia-Ukraine War Causing Problems For Multiple Sclerosis Trials
Via Benzinga
COVID-19 Tests Boost Roche's Q1 Sales, Reaffirms FY22 Outlook
Via Benzinga
EMA' Advisory Committee Recommends Approval For Roche's Two Cancer Drugs
Via Benzinga
7 Potential Biotech Stocks Buyout Targets in 2022
Via InvestorPlace
FDA Warns Against Relying On Screening Tests For Prenatal Diagnosis
Via Benzinga
4 Undervalued Biotech Stocks to Add to Your Buy List
Via InvestorPlace
Lessons For Elon Musk: 5 Notorious Failed Hostile Takeovers
Via Talk Markets
Lessons For Elon Musk: 5 Notorious Failed Hostile Takeovers
Via Benzinga
FDA Extends Review Period For Regeneron's COVID-19 Antibody Therapy
Via Benzinga
Volume Springs Back Into The OTC Markets In March – Take A Look At Some Of The Top Movers
Via Benzinga
Read Why Pliant Therapeutics Shares Are Soaring Today
Via Benzinga
The Daily Biotech Pulse: GlaxoSmithKline And Halozyme Go Shopping, Mylan's Insulin Glargine Recall, Turning Point Shares Lung Cancer Data And More
Via Benzinga
Healthcare Stocks Lead the Way Up as the Market Fades
Via Talk Markets
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.